PLC (NASDAQ:SMX)(NASDAQ:SMXWW), a global pioneer in digitizing physical objects for a circular economy, today announced the ...
Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results